• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种实验室风险评分,用于早期预测 COVID-19 严重程度和住院死亡率。

Development and validation of a laboratory risk score for the early prediction of COVID-19 severity and in-hospital mortality.

机构信息

Central Laboratory of Clinical Biology, University Hospital Center of Blida, 9000 Blida, Algeria.

Department of Internal Medicine and Cardiology, University Hospital Center of Blida. 9000 Blida, Algeria.

出版信息

Intensive Crit Care Nurs. 2021 Jun;64:103012. doi: 10.1016/j.iccn.2021.103012. Epub 2021 Jan 9.

DOI:10.1016/j.iccn.2021.103012
PMID:33487518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834685/
Abstract

BACKGROUND AND AIMS

Coronavirus Disease 2019 is characterized by a spectrum of clinical severity. This study aimed to develop a laboratory score system to identify high-risk individuals, to validate this score in a separate cohort, and to test its accuracy in the prediction of in-hospital mortality.

METHODS

In this cohort study, biological data from 330 SARS-CoV-2 infected patients were used to develop a risk score to predict progression toward severity. In a second stage, data from 240 additional COVID-19 patients were used to validate this score. Accuracy of the score was measured by the area under the receiver operating characteristic curve (AUC).

RESULTS

In the development cohort, a step-wise decrease in the average survival duration was noted with the increment of the risk score (p < 0.0001). A similar trend was confirmed when analyzing this association in the validation cohort (p < 0.0001). The AUC was 0.74 [0.66-0.82] and 0.90 [0.87-0.94], p < 0.0001, respectively for severity and mortality prediction.

CONCLUSION

This study provides a useful risk score based on biological routine parameters assessed at the time of admission, which has proven its effectiveness in predicting both severity and short-term mortality of COVID-19. Improved predictive scores may be generated by including other clinical and radiological features.

摘要

背景与目的

2019 年冠状病毒病(COVID-19)的临床严重程度表现出一定的范围。本研究旨在开发一种实验室评分系统,以识别高危人群,并在独立队列中验证该评分,同时检验其对住院死亡率预测的准确性。

方法

在这项队列研究中,使用了 330 名 SARS-CoV-2 感染患者的生物学数据来开发预测疾病严重程度进展的风险评分。在第二阶段,使用了 240 名额外的 COVID-19 患者的数据来验证该评分。采用受试者工作特征曲线下面积(AUC)来衡量评分的准确性。

结果

在开发队列中,随着风险评分的增加,平均存活时间呈逐步下降趋势(p<0.0001)。在验证队列中分析这种相关性时也得到了类似的趋势(p<0.0001)。严重程度和死亡率预测的 AUC 分别为 0.74[0.66-0.82]和 0.90[0.87-0.94],p<0.0001。

结论

本研究基于入院时评估的生物学常规参数提供了一种有用的风险评分,该评分已被证明可有效预测 COVID-19 的严重程度和短期死亡率。通过纳入其他临床和影像学特征,可能会生成更具预测能力的评分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/861dc0d145f7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/c47f26a6d7c8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/08d56842afe2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/861dc0d145f7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/c47f26a6d7c8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/08d56842afe2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777b/7834685/861dc0d145f7/gr3_lrg.jpg

相似文献

1
Development and validation of a laboratory risk score for the early prediction of COVID-19 severity and in-hospital mortality.开发和验证一种实验室风险评分,用于早期预测 COVID-19 严重程度和住院死亡率。
Intensive Crit Care Nurs. 2021 Jun;64:103012. doi: 10.1016/j.iccn.2021.103012. Epub 2021 Jan 9.
2
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
3
National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.入院时的国家早期预警评分 2 (NEWS2)可预测新冠病毒疾病的严重程度和住院死亡率-一项前瞻性队列研究。
Scand J Trauma Resusc Emerg Med. 2020 Jul 13;28(1):66. doi: 10.1186/s13049-020-00764-3.
4
A Clinical Risk Score to Predict In-hospital Mortality from COVID-19 in South Korea.韩国用于预测 COVID-19 住院患者死亡率的临床风险评分
J Korean Med Sci. 2021 Apr 19;36(15):e108. doi: 10.3346/jkms.2021.36.e108.
5
Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score.利用即时检验风险预测评分对 COVID-19 进行早期预后预测,以指导住院治疗或门诊监测。
Thorax. 2021 Jul;76(7):696-703. doi: 10.1136/thoraxjnl-2020-216425. Epub 2021 Mar 10.
6
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.利用美国国家 COVID 队列协作的数据,对美国成年人中 SARS-CoV-2 感染的临床特征和临床严重程度进行临床描述和预测。
JAMA Netw Open. 2021 Jul 1;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901.
7
Generation and validation of in-hospital mortality prediction score in COVID-19 patients: Alba-score.新冠肺炎患者院内死亡率预测评分 Alba-score 的生成与验证。
Curr Med Res Opin. 2021 May;37(5):719-726. doi: 10.1080/03007995.2021.1891036. Epub 2021 Mar 12.
8
Prediction of mortality in COVID-19 through combing CT severity score with NEWS, qSOFA, or peripheral perfusion index.通过将 CT 严重程度评分与 NEWS、qSOFA 或外周灌注指数相结合预测 COVID-19 患者的死亡率。
Am J Emerg Med. 2021 Dec;50:546-552. doi: 10.1016/j.ajem.2021.08.079. Epub 2021 Sep 2.
9
Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting.社区医院环境中 COVID-19 住院患者的快速 COVID-19 严重程度指数和布雷西亚-COVID 呼吸严重程度量表的性能。
Int J Infect Dis. 2021 Jan;102:571-576. doi: 10.1016/j.ijid.2020.11.003. Epub 2020 Nov 9.
10
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.利用 ISARIC WHO 临床特征协议对因 COVID-19 住院的患者进行风险分层:4C 死亡率评分的制定和验证。
BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339.

引用本文的文献

1
Prediction models based on machine learning algorithms for COVID-19 severity risk.基于机器学习算法的新型冠状病毒肺炎严重程度风险预测模型。
BMC Public Health. 2025 May 13;25(1):1748. doi: 10.1186/s12889-025-22976-x.
2
Validation of prognostic models predicting mortality or ICU admission in patients with COVID-19 in low- and middle-income countries: a global individual participant data meta-analysis.低收入和中等收入国家中预测COVID-19患者死亡率或入住重症监护病房的预后模型的验证:一项全球个体参与者数据荟萃分析
Diagn Progn Res. 2024 Dec 19;8(1):17. doi: 10.1186/s41512-024-00181-5.
3
Prognostic models in COVID-19 infection that predict severity: a systematic review.

本文引用的文献

1
Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.生物标志物在预测 2019 年冠状病毒病严重程度中的作用。
Scand J Clin Lab Invest. 2020 Dec;80(8):611-618. doi: 10.1080/00365513.2020.1821396. Epub 2020 Sep 18.
2
Nursing workload in the COVID-19 era.新冠疫情时代的护理工作量。
Intensive Crit Care Nurs. 2020 Dec;61:102929. doi: 10.1016/j.iccn.2020.102929. Epub 2020 Aug 11.
3
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study.
COVID-19 感染中预测严重程度的预后模型:系统评价。
Eur J Epidemiol. 2023 Apr;38(4):355-372. doi: 10.1007/s10654-023-00973-x. Epub 2023 Feb 25.
4
Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity.将新冠肺炎患者的肺部疾病进行自动化定量分析,作为评估住院严重程度的预测工具。
Front Med (Lausanne). 2022 Aug 29;9:930055. doi: 10.3389/fmed.2022.930055. eCollection 2022.
5
Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis.实验室评分系统预测 COVID-19 患者严重程度的开发:一项回顾性分析。
PLoS One. 2022 Sep 9;17(9):e0273006. doi: 10.1371/journal.pone.0273006. eCollection 2022.
6
The Role of Biochemical and Respiratory Markers in the Mortality of Patients With SARS-CoV-2 Infection in a Mexican Population.生化和呼吸标志物在墨西哥人群中感染新型冠状病毒2的患者死亡率中的作用。
Cureus. 2022 Jun 23;14(6):e26249. doi: 10.7759/cureus.26249. eCollection 2022 Jun.
7
Predicting the Disease Severity of Virus Infection.预测病毒感染的疾病严重程度。
Adv Exp Med Biol. 2022;1368:111-139. doi: 10.1007/978-981-16-8969-7_6.
8
A simple risk score for mortality including the PCR Ct value upon admission in patients hospitalized due to COVID-19.一个简单的死亡率风险评分,包含因 COVID-19 住院患者入院时的 PCR Ct 值。
Infection. 2022 Oct;50(5):1155-1163. doi: 10.1007/s15010-022-01783-1. Epub 2022 Feb 26.
9
External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals.COVID-19 预后评分的外部验证:大巴黎大学医院住院患者的多中心队列研究。
Intensive Care Med. 2021 Dec;47(12):1426-1439. doi: 10.1007/s00134-021-06524-w. Epub 2021 Sep 28.
10
Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients.入院时心脏脂肪组织体积和白细胞介素 6 水平是 COVID-19 糖尿病患者严重程度和短期死亡率的补充预测指标。
Cardiovasc Diabetol. 2021 Aug 12;20(1):165. doi: 10.1186/s12933-021-01327-1.
一种用于识别 COVID-19 患者有入住重症监护病房或死亡高风险的临床风险评分:一项观察性队列研究。
J Infect. 2020 Aug;81(2):282-288. doi: 10.1016/j.jinf.2020.05.064. Epub 2020 May 29.
4
Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine.基于中医理论的新型冠状病毒肺炎的诊断与治疗。
J Integr Med. 2020 Jul;18(4):275-283. doi: 10.1016/j.joim.2020.04.001. Epub 2020 Apr 15.
5
Hypolipidemia is associated with the severity of COVID-19.血脂异常与 COVID-19 的严重程度有关。
J Clin Lipidol. 2020 May-Jun;14(3):297-304. doi: 10.1016/j.jacl.2020.04.008. Epub 2020 Apr 30.
6
Clinical significance of nutritional risk screening for older adult patients with COVID-19.老年 COVID-19 患者营养风险筛查的临床意义。
Eur J Clin Nutr. 2020 Jun;74(6):876-883. doi: 10.1038/s41430-020-0659-7. Epub 2020 May 13.
7
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
8
ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.ESPEN 专家声明和关于 SARS-CoV-2 感染个体营养管理的实用指南。
Clin Nutr. 2020 Jun;39(6):1631-1638. doi: 10.1016/j.clnu.2020.03.022. Epub 2020 Mar 31.
9
A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.一种用于早期预测严重 2019 冠状病毒病(COVID-19)的工具:来自中国武汉和广东的多中心研究使用风险列线图。
Clin Infect Dis. 2020 Jul 28;71(15):833-840. doi: 10.1093/cid/ciaa443.
10
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.